Affiliate disclosure: As an Amazon Associate, AgmatineHub earns from qualifying purchases. This helps support our research and content creation, and it does not affect what we recommend. Full disclosure.
Both of these get recommended for stress, and the recommendations tend to sound equally confident. They should not. L-theanine has been through human randomised controlled trials and a systematic review of them. Agmatine has a richer mechanistic account and a much thinner human record.
That does not automatically make theanine the better choice for everyone, but it does mean the two claims are not the same kind of claim.
Key Takeaways
- A systematic review following PRISMA identified 9 peer-reviewed human randomised controlled trials of pure L-theanine supplementation against a control, and concluded that 200 to 400 mg per day may assist in reducing stress and anxiety in people exposed to stressful conditions [1].
- The same review was explicit that longer-term and larger-cohort clinical studies are still needed before L-theanine can be clinically justified as a therapeutic agent [1].
- Agmatine has an unusually detailed mechanistic case for mood: oral dosing in mice produced antidepressant-like effects that were blocked by AMPA receptor, TrkB, PI3K and mTOR inhibitors, and increased BDNF, PSD-95 and GluA1 in prefrontal cortex within 1 hour [2].
- That pathway is the same one implicated in fast-acting antidepressants, which is scientifically interesting and not a substitute for a human anxiety trial [2].
- L-theanine is well characterised for acute, situational stress. Agmatine has no comparable human trial in healthy adults under stress.
- The practical read: theanine is the lower-risk, better-evidenced option for everyday stress. Agmatine is a research-stage compound whose mood story is preclinical.
What L-Theanine Has Behind It
L-theanine is an amino acid found almost exclusively in tea, and it is responsible for much of the reason people describe tea as calming without being sedating. It crosses the blood-brain barrier and is generally described as promoting alpha-wave activity and modulating glutamate and GABA signalling.
A systematic review conducted according to PRISMA methodology set out to evaluate pure L-theanine taken as an oral supplement, comparing it against a control in human randomised controlled trials. Nine peer-reviewed articles met that specification. The conclusion was that supplementation of 200 to 400 mg per day may assist in reducing stress and anxiety in people exposed to stressful conditions [1].
The authors then did something worth crediting: they immediately qualified it. Longer term and larger cohort clinical studies, including ones where theanine is incorporated regularly into the diet, are needed before its use as a therapeutic agent for stress and anxiety can be clinically justified [1]. So the honest summary is “modest human support, appropriate for situational stress, not established as therapy.”
Note also what the review scoped out. It covered pure L-theanine supplements, not theanine-plus-caffeine combinations, which are studied separately and behave differently because the caffeine is doing much of the work.
What Agmatine Has Behind It
Agmatine has a mechanistic story that is, frankly, more interesting than theanine has. It is just not human.
In a study published in European Neuropsychopharmacology, oral agmatine at 0.1 mg/kg significantly reduced immobility time in the mouse tail suspension test, a standard antidepressant screen. The interesting part was the blockade experiments. The effect was prevented by DNQX (an AMPA receptor antagonist), by a BDNF antibody, by K-252a (a TrkB antagonist), by LY294002 (a PI3K inhibitor), and by rapamycin (a selective mTOR inhibitor) [2].
In other words, knock out any step in the AMPA to BDNF to TrkB to PI3K to mTOR chain and the agmatine effect disappears. On top of that, within one hour of administration, the prefrontal cortex showed increased levels of BDNF, PSD-95 and GluA1, all markers of synaptic strengthening [2].
That chain is the pathway associated with fast-acting antidepressants. It is a strong preclinical result. It is also a mouse behavioural screen, at a dose that does not translate simply, and it addresses depressive-like behaviour rather than anxiety in stressed but healthy humans.
Comparing Like With Like
For everyday situational stress
Theanine is the better-supported option, and it is not close. Nine human randomised trials in a systematic review beats zero. The dose range with support is 200 to 400 mg per day [1], which is well above what a cup of tea provides, so the supplement form is doing something the beverage does not.
For mechanism-driven interest
Agmatine is the more compelling molecule on paper. The AMPA and mTOR dependence is a genuinely notable finding, and the wider receptor profile touching imidazoline, alpha-2 and NMDA systems gives it more plausible routes to affect stress physiology than theanine has [3]. That is a reason to follow the research, not a reason to expect a result.
For safety margin
Theanine has the longer human exposure history and a very quiet adverse event profile. Agmatine has known interaction concerns worth taking seriously, particularly around blood pressure medication and antidepressants, because of its imidazoline and alpha-2 activity. Anyone on prescription psychiatric or cardiovascular medication should treat agmatine as requiring a conversation with their prescriber, not as an obvious add-on.
Can They Be Combined?
There is no study of the combination. Mechanistically they are not obviously in conflict, and theanine is unusually benign. But the combination has not been tested, and stacking two compounds when only one has human evidence mostly makes it harder to know what produced any effect you notice.
If the goal is to evaluate whether either does anything for you, running one at a time for a few weeks is the only approach that produces interpretable information.
A Note on the Evidence
Agmatine sulfate is not FDA-approved to diagnose, treat, cure, or prevent any disease. This article is informational only and does not constitute medical advice.
Frequently Asked Questions
Is L-theanine better than agmatine for anxiety?
For everyday stress and anxiety, yes, on the evidence. L-theanine has nine human randomised controlled trials summarised in a systematic review supporting 200 to 400 mg per day for people under stressful conditions. Agmatine has no comparable human anxiety trial, only preclinical work.
How much L-theanine did the studies use?
The systematic review concluded that 200 to 400 mg per day may help reduce stress and anxiety in people exposed to stressful conditions. That is substantially more than a cup of tea delivers. The same review stressed that longer and larger trials are still needed before theanine can be clinically justified as a therapeutic agent.
Why do people say agmatine works like ketamine?
Because a mouse study found the antidepressant-like effect of oral agmatine was abolished by blocking AMPA receptors, BDNF, TrkB, PI3K or mTOR, which is the same signalling chain implicated in fast-acting antidepressants, and prefrontal BDNF, PSD-95 and GluA1 rose within an hour. That is a mechanistic parallel in rodents, not a demonstrated clinical equivalence in people.
Can I take agmatine and L-theanine together?
No study has tested the combination and there is no obvious mechanistic conflict. The practical objection is different: if you take both at once and feel better, you will not know which one did it. Running one at a time gives you interpretable information. Anyone on blood pressure or antidepressant medication should discuss agmatine with a prescriber first.
References
- Williams JL, et al. The Effects of Green Tea Amino Acid L-Theanine Consumption on the Ability to Manage Stress and Anxiety Levels: a Systematic Review. Plant Foods Hum Nutr (2020). PMID 31758301
- Neis VB, et al. Agmatine produces antidepressant-like effects by activating AMPA receptors and mTOR signaling. Eur Neuropsychopharmacol (2016). PMID 27061850
- Kaur A, Kaur R, et al. Pharmacological profile of agmatine: An in-depth overview. Neuropeptides (2024). PMID 38608401
These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure, or prevent any disease. Content is for informational purposes only and is not medical advice; consult a qualified healthcare provider before starting any supplement. As an Amazon Associate we earn from qualifying purchases.
